Creatine through menopause: what we know, and the honest gaps

Menopause brings a drop in estrogen that accelerates muscle and bone loss and, for many women, adds sleep trouble, mood swings and brain fog. Creatine has become one of the most talked-about tools for this transition. Here's the honest split between what's supported and what's still emerging.

The strongest evidence is after menopause

For postmenopausal women, the muscle and strength case is solid. Combined with resistance training, creatine adds meaningfully to the strength and lean-mass gains that training produces on its own — the same effect seen across the lifespan, and reinforced by the major 2025 review of creatine in women's health (Smith-Ryan et al., 2025; Smith-Ryan et al., 2021). Since estrogen loss speeds up muscle and bone decline, this is exactly the window where holding on to strength matters most.

Perimenopause was a real gap — now getting its first data

Until recently there were essentially no trials in perimenopausal women — an honest hole we've flagged before. That's starting to change. A 2025 randomised controlled trial in 36 peri- and menopausal women (CONCRET-MENOPA) found that a medium dose of creatine improved reaction time and frontal-lobe brain creatine, with a signal toward fewer mood swings (Korovljev et al., 2025).

Two honest caveats: it's a small study split across four groups, and it used creatine hydrochloride and ethyl ester, not the monohydrate that the rest of the evidence base — and our product — is built on. It's an encouraging first step, not a settled result.

Mood, sleep and brain fog: promising, early

The 2025 review highlights emerging signals for mood, cognition and sleep during the menopause transition — the symptoms women most often report (Smith-Ryan et al., 2025). This fits creatine's role as a brain energy buffer, and it's genuinely interesting, but the trials are small and short. Promising, not proven — and there's no EU-authorised health claim for creatine and cognition or mood. We keep those in the Journal, not on the label.

How to use it

• 3–5 g of creatine monohydrate a day, consistently — the form and dose the evidence actually rests on.
• Pair it with resistance training if strength and bone are the goal; the training does the heavy lifting.
• Well tolerated; if you have kidney disease, check with your doctor. See creatine myths for the safety picture, and note that creatine in pregnancy isn't well studied — don't start new supplements then without medical advice.

In short

After menopause, creatine plus training is a well-supported way to defend strength and muscle. Through perimenopause and for mood, sleep and cognition, the science is early but moving fast — and finally being done in the women it applies to. More in creatine for women and the simple guide.

Sources

• Smith-Ryan et al. (2025). Creatine in women's health: bridging the gap from menstruation through pregnancy to menopause. Journal of the International Society of Sports Nutrition.
• Smith-Ryan, Cabre, Eckerson & Candow (2021). Creatine Supplementation in Women's Health: A Lifespan Perspective. Nutrients.
• Korovljev et al. (2025). The effects of 8-week creatine hydrochloride and creatine ethyl ester supplementation on cognition, clinical outcomes, and brain creatine levels in perimenopausal and menopausal women (CONCRET-MENOPA): a randomized controlled trial. Journal of the American Nutrition Association.
• EU register of authorised health claims — creatine (physical performance; muscle strength in adults over 55).